AH amyloid neuropathy: a novel clinical phenotype confirmed by histopathology and mass spectrometry

Nobuhiko Ohashia Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, JapanView further author information

Nagaaki Katohb Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto390-8621, JapanCorrespondence[email protected]
View further author information

Kazuki Kasugaa Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, JapanView further author information

Tsuneaki Yoshinagaa Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, JapanView further author information

Fuyuki Kametanic Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, JapanView further author information

Masahide Yazakid Clinical Laboratory Sciences Division, Shinshu University Graduate of School of Medicine, Matsumoto, Japan;e Institute for Biomedical Sciences, Shinshu University, Matsumoto, JapanView further author information

Yoshiki Sekijimaa Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan;e Institute for Biomedical Sciences, Shinshu University, Matsumoto, JapanView further author information

show all

References

Nasr SH, Said SM, Valeri AM, et al. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis. Kidney Int. 2013;83(3):463–470.
PubMed Web of Science ®Google Scholar
Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. The Lancet. 2016;387(10038):2641–2654.
PubMed Web of Science ®Google Scholar
Minori K, Satoshi K, Kamijo Y, et al. Muscle training-induced bilateral brachial plexopathy in an adolescent with sporadic hereditary neuropathy with liability to pressure palsies. Brain Behav. 2017;7(9):e00783.
PubMed Web of Science ®Google Scholar
Abe R, Katoh N, Takahashi Y, et al. Distribution of amyloidosis subtypes based on tissue biopsy site – consecutive analysis of 729 patients at a single amyloidosis center in Japan. Pathol Int. 2021;71(1):70–79.
PubMed Web of Science ®Google Scholar
Kametani F, Haga S. Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B. Neurobiol Aging. 2015;36(2):634–637.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

AH amyloid neuropathy: a novel clinical phenotype confirmed by histopathology and mass spectrometry

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

AH amyloid neuropathy: a novel clinical phenotype confirmed by histopathology and mass spectrometry

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date